Manenti, 141 patient colchicine late treatment study: 76% lower mortality [p=0.005] and 44% improved recovery [p=0.05] https://c19p.org/manenti
copied to clipboard
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study
et al., PLOS ONE, doi:10.1371/journal.pone.0248276
IPTW retrospective 141 COVID-19 patients (83% hospitalized), 71 treated with colchicine and 70 matched control patients, showing lower mortality and faster recovery with treatment.
|
risk of death, 76.0% lower, HR 0.24, p = 0.005, treatment 71, control 70, adjusted per study, propensity score weighting.
|
|
risk of no recovery, 44.4% lower, RR 0.56, p = 0.048, treatment 71, control 70, adjusted per study, propensity score weighting.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Manenti et al., 3/24/2021, retrospective, Italy, Europe, peer-reviewed, 24 authors, study period 1 March, 2020 - 10 April, 2020.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.